Document Detail


All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.
MedLine Citation:
PMID:  19903021     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Retinoic acid, an essential factor derived from vitamin A, has been shown to have a variety of functions including roles as an antioxidant and in cellular differentiation. Since oxidative stress and dedifferentiation of neurons appear to be common pathological elements of a number of neurodegenerative disorders, we speculated that retinoic acid may offer therapeutic promise. In this vein, recent compelling evidence indicates a role of retinoic acid in cognitive activities and anti-amyloidogenic properties. Here, we review the actions of retinoic acid that indicate that it may have therapeutic properties ideally served for the treatment of neurodegenerative diseases such as Alzheimer's disease.
Authors:
Hyun-Pil Lee; Gemma Casadesus; Xiongwei Zhu; Hyoung-gon Lee; George Perry; Mark A Smith; Katarzyna Gustaw-Rothenberg; Alan Lerner
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  9     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-11     Completed Date:  2010-01-22     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1615-21     Citation Subset:  IM    
Affiliation:
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA. hxl204@case.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / drug therapy*
Animals
Brain / drug effects*
Humans
Neuroprotective Agents / pharmacology*
Tretinoin / pharmacology*
Grant Support
ID/Acronym/Agency:
R01 AG026151/AG/NIA NIH HHS; R01 AG026151-03/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Neuroprotective Agents; 302-79-4/Tretinoin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine.
Next Document:  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?